Cardio Diagnostics Holdgs Inc.

13F holders, Q1 2024 (March 31)
14holders
$1.42avg. 13F price*

At the end of Q1 2024, 14 institutions reported holding Cardio Diagnostics Holdgs Inc. in their 13F filings. The largest holders were BlackRock Inc. ($1.5M), Vanguard Group Inc. ($330K) and Geode Capital Management, LLC ($216K).

Company
Cardio Diagnostics Holdgs Inc.
CUSIP
14159C103
Latest filing quarter
Q1 2025

History

Number of 13F holders

0510152025 Q1 2024: 14Q1 2024Q2 2024: 16Q2 2024Q3 2024: 15Q3 2024Q4 2024: 23Q4 2024Q1 2025: 23Q1 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions2$42K
Exits2$211K

Ownership 14 holders

BlackRock Inc. 0.00% No change 1,067,062 $1.5M
Vanguard Group Inc. 0.00% No change 232,139 $330K
Geode Capital Management, LLC 0.00% Add +10.0% 152,292 $216K
State Street Corp. 0.00% Add +116.4% 43,500 $62K
PNC Financial Services Group, Inc. 0.00% No change 40,500 $58K
Northern Trust Corp. 0.00% Reduce -43.0% 26,295 $37K
Two Sigma Securities, LLC 0.00% New 16,927 $24K
UBS Group AG 0.00% New 12,520 $18K
Vontobel Holding Ltd. 0.00% No change 12,000 $17K
Caldwell Sutter Capital, Inc. 0.01% No change 8,101 $12K
Tower Research Capital LLC (TRC) 0.00% Add +44.8% 4,026 $6K
Wolverine Asset Management LLC 0.00% Add +5.7% 3,777 $5K
Osaic Holdings, Inc. 0.00% Add +530.0% 3,150 $4K
Wells Fargo & Company 0.00% Add +14.5% 134 $190

"% of holder's portfolio" is CARDIO DIAGNOSTICS HOLDGS IN's weight in each manager's 13F, not the share of Cardio Diagnostics Holdgs Inc. the manager owns.